Yutaka Kitano, Chika Komiyama, Mitsuhiro Makino, Yoshio Kasai, Kiyoshi Takasuna, Masakazu Kinoshita, Osamu Yamazaki, Akira Takazawa, Toshio Yamauchi, Shinobu Sakurada
Index: Epilepsia 46(10) , 1561-8, (2005)
Full Text: HTML
Nefiracetam (NEF) is a novel pyrrolidonetype nootropic agent, and it has been reported to possess various pharmacologic effects as well as cognition-enhancing effects. The present study focused on the effects of NEF in amygdala-kindled seizures and its potential for antiepileptic therapy.Effects of NEF on fully amygdala-kindled seizures and development of amygdala-kindled seizures were investigated in rats and compared with those of levetiracetam (LEV), a pyrrolidone-type antiepileptic drug (AED).In fully amygdala-kindled rats, NEF (25, 50, and 100 mg/kg, p.o.) decreased afterdischarge induction, afterdischarge duration, seizure stage, and motor seizure duration in a dose-dependent manner. LEV (25, 50, and 100 mg/kg, p.o.) had no effects on afterdischarge induction and slightly decreased afterdischarge duration, whereas it markedly decreased seizure stage and motor seizure duration. In contrast to the results in fully amygdala-kindled rats, NEF (25 and 50 mg/kg/day, p.o.) had few or no effects on the development of amygdala-kindled seizures. As well as fully amygdala-kindled seizures, LEV (50 mg/kg/day, p.o.) markedly inhibited the development of behavioral seizures without reducing daily afterdischarge duration.Although NEF possesses potent anticonvulsant effects on fully amygdala-kindled seizures, it has few or no effects on the development of amygdala-kindled seizures. LEV shows marked anticonvulsant effects on both phases of kindling. In fully amygdala-kindled rats, NEF inhibits both electroencephalographic and behavioral seizures, whereas LEV inhibits only behavioral seizures. This double dissociation suggests that NEF has a distinct anticonvulsant spectrum and mechanisms from those of LEV.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Nefiracetam
CAS:77191-36-7 |
C14H18N2O2 |
|
Investigation on urinary proteins and renal mRNA expression ...
2005-09-01 [Arch. Toxicol. 79(9) , 500-7, (2005)] |
|
Nefiracetam and galantamine modulation of excitatory and inh...
2009-05-05 [Neuroscience 160(2) , 484-91, (2009)] |
|
Anticonvulsant properties of the novel nootropic agent nefir...
2005-06-01 [Epilepsia 46(6) , 811-8, (2005)] |
|
Negative regulation of opioid receptor-G protein-Ca2+ channe...
2004-10-01 [Ann. N. Y. Acad. Sci. 1025 , 389-97, (2004)] |
|
Nefiracetam, a novel cognition-enhancing agent. An introduct...
1994-02-01 [Arzneimittelforschung 44(2A) , 193-4, (1994)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
